IVIg Reduces Infection Rate in Multiple Myeloma Patients Receiving Anti-BCMA Therapy
Reduction in grade 3 to 5 infections seen among patients with multiple myeloma treated with BCMA-targeted bispecific antibodies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.